Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Enterprise Value (EV)

Microsoft Excel

Current Enterprise Value (EV)

Allergan PLC, current enterprise value calculation

Microsoft Excel
Current share price (P) $192.99
No. shares of common stock outstanding 329,805,791
US$ in thousands
Common equity (market value)1 63,649,220
Add: Preferred shares, $0.0001 par value per share (per books)
Add: Noncontrolling interest (per books) 22,800
Total equity 63,672,020
Add: Current portion of long-term debt and capital leases (per books) 4,532,500
Add: Long-term debt and capital leases, excluding current portion (per books) 18,116,500
Total equity and debt 86,321,020
Less: Cash and cash equivalents 2,503,300
Less: Marketable securities 3,411,600
Enterprise value (EV) 80,406,120

Based on: 10-K (reporting date: 2019-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 192.99 × 329,805,791


Historical Enterprise Value (EV)

Allergan PLC, EV calculation

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Share price1, 2 $198.00 $139.07 $164.04 $245.37 $298.07
No. shares of common stock outstanding1 329,002,015 332,614,474 330,320,420 335,224,713 394,687,384
US$ in thousands
Common equity (market value)3 65,142,399 46,256,695 54,185,762 82,254,088 117,644,469
Add: Preferred shares, $0.0001 par value per share (book value) 4,929,700 4,929,700 4,929,700
Add: Noncontrolling interest (book value) 22,800 16,900 16,000 7,800 (2,100)
Total equity 65,165,199 46,273,595 59,131,462 87,191,588 122,572,069
Add: Current portion of long-term debt and capital leases (book value) 4,532,500 868,300 4,231,800 2,797,900 2,432,800
Add: Long-term debt and capital leases, excluding current portion (book value) 18,116,500 22,929,400 25,843,500 29,970,800 40,293,400
Total equity and debt 87,814,199 70,071,295 89,206,762 119,960,288 165,298,269
Less: Cash and cash equivalents 2,503,300 880,400 1,817,200 1,724,000 1,096,000
Less: Marketable securities 3,411,600 1,026,900 4,632,100 11,501,500 9,300
Enterprise value (EV) 81,899,299 68,163,995 82,757,462 106,734,788 164,192,969

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Allergan PLC Annual Report.

3 2019 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 198.00 × 329,002,015

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Allergan PLC EV decreased from 2017 to 2018 but then increased from 2018 to 2019 not reaching 2017 level.